BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1452 related articles for article (PubMed ID: 18752108)

  • 1. The relationship between alexithymia and salivary cortisol levels in somatoform disorders.
    Pedrosa Gil F; Bidlingmaier M; Ridout N; Scheidt CE; Caton S; Schoechlin C; Nickel M
    Nord J Psychiatry; 2008; 62(5):366-73. PubMed ID: 18752108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].
    De Chouly De Lenclave MB; Florequin C; Bailly D
    Encephale; 2001; 27(4):343-50. PubMed ID: 11686056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alexithymia and temperament and character model of personality in patients with major depressive disorder.
    Celikel FC; Kose S; Erkorkmaz U; Sayar K; Cumurcu BE; Cloninger CR
    Compr Psychiatry; 2010; 51(1):64-70. PubMed ID: 19932828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inpatient psychotherapy on the stability of alexithymia characteristics.
    Stingl M; Bausch S; Walter B; Kagerer S; Leichsenring F; Leweke F
    J Psychosom Res; 2008 Aug; 65(2):173-80. PubMed ID: 18655863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol.
    Edwards KM; Bosch JA; Engeland CG; Cacioppo JT; Marucha PT
    Brain Behav Immun; 2010 Oct; 24(7):1202-8. PubMed ID: 20382217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between alexithymia, alexithymia factors and salivary cortisol in men exposed to a social stress test.
    de Timary P; Roy E; Luminet O; Fillée C; Mikolajczak M
    Psychoneuroendocrinology; 2008 Sep; 33(8):1160-4. PubMed ID: 18674866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatic symptoms of depression].
    Güleç H; Sayar K; Ozkorumak E
    Turk Psikiyatri Derg; 2005; 16(2):90-6. PubMed ID: 15981146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders.
    Veen G; Giltay EJ; DeRijk RH; van Vliet IM; van Pelt J; Zitman FG
    Metabolism; 2009 Jun; 58(6):821-7. PubMed ID: 19375126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexithymia and somatization in general population.
    Mattila AK; Kronholm E; Jula A; Salminen JK; Koivisto AM; Mielonen RL; Joukamaa M
    Psychosom Med; 2008 Jul; 70(6):716-22. PubMed ID: 18596251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders.
    Koh KB; Kim DK; Kim SY; Park JK; Han M
    Psychiatry Res; 2008 Sep; 160(3):372-9. PubMed ID: 18718675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between the dimensions of alexithymia and the intensity of depression and anxiety].
    Motan I; Gençöz T
    Turk Psikiyatri Derg; 2007; 18(4):333-43. PubMed ID: 18066724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alexithymia and interleukin variations in somatoform disorder.
    Pedrosa Gil F; Nickel M; Ridout N; Schwarz MJ; Schoechlin C; Schmidmaier R
    Neuroimmunomodulation; 2007; 14(5):235-42. PubMed ID: 18073498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The self-perceived symptom distress and health-related conditions associated with morning to evening diurnal cortisol patterns in outpatients with major depressive disorder.
    Hsiao FH; Yang TT; Ho RT; Jow GM; Ng SM; Chan CL; Lai YM; Chen YT; Wang KC
    Psychoneuroendocrinology; 2010 May; 35(4):503-15. PubMed ID: 19775819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does the Toronto Alexithymia Scale TAS-R measure?
    Rief W; Heuser J; Fichter MM
    J Clin Psychol; 1996 Jul; 52(4):423-9. PubMed ID: 8842878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary cortisol and suicidal behavior--a follow-up study.
    Lindqvist D; Isaksson A; Träskman-Bendz L; Brundin L
    Psychoneuroendocrinology; 2008 Sep; 33(8):1061-8. PubMed ID: 18672335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and physiological effects of caring for patients with treatment-resistant depression.
    Rane LJ; Fekadu A; Papadopoulos AS; Wooderson SC; Poon L; Markopoulou K; Cleare AJ
    Psychol Med; 2012 Sep; 42(9):1825-33. PubMed ID: 22251699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA system activity in alexithymia: a cortisol awakening response study.
    Alkan Härtwig E; Aust S; Heuser I
    Psychoneuroendocrinology; 2013 Oct; 38(10):2121-6. PubMed ID: 23627992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive personality dimensions and alexithymia in eating disorders.
    Speranza M; Corcos M; Loas G; Stéphan P; Guilbaud O; Perez-Diaz F; Venisse JL; Bizouard P; Halfon O; Flament M; Jeammet P
    Psychiatry Res; 2005 Jun; 135(2):153-63. PubMed ID: 15913785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.